MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, DERM made $17,631,000 in revenue. -$2,315,000 in net income. Net profit margin of -13.13%.

Income Overview

Revenue
$17,631,000
Net Income
-$2,315,000
Net Profit Margin
-13.13%
EPS
-$0.09
Unit: Dollar
Revenue Breakdown
    • Qbrexza
    • Emrosi
    • Accutane
    • Others
Revenue Breakdown
    • Revenue from contract with custo...
    • Other income

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue
17,631,000 15,009,000 13,139,000 13,325,000
Cost of goods sold - (excluding amortization of acquired intangible assets)
5,755,000 4,939,000 4,790,000 4,526,500
Amortization of acquired intangible assets
1,064,000 1,064,000 1,065,000 856,000
Research and development
287,000 -39,000 4,051,000
Loss recovery
---1,138,250
Selling, general and administrative
12,054,000 11,882,000 10,569,000 9,240,000
Total operating expenses
19,160,000 17,885,000 16,463,000 17,253,000
Loss from operations
-1,529,000 -2,876,000 -3,324,000 -3,928,000
Interest income
154,000 138,000 149,000 204,000
Interest expense
937,000 937,000 891,000 689,500
Gain on extinguishment of debt
---0
Foreign exchange transaction losses
-3,000 -61,000 -7,000 -16,500
Total other expense (income)
-786,000 -860,000 -749,000 -502,000
Loss before income taxes
-2,315,000 -3,736,000 -4,073,000 -4,430,000
Income tax expense
-60,000 -15,250
Net loss
-2,315,000 -3,796,000 -4,073,000 -4,460,500
Earnings per share, basic
-0.09 -0.16 -0.18 -0.215
Earnings per share, diluted
-0.09 -0.16 -0.18 -0.215
Weighted average number of shares outstanding, basic
24,959,114 23,290,806 22,611,040 -10,050,126
Weighted average number of shares outstanding, diluted
24,959,114 23,290,806 22,611,040 -10,050,126
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,315,000 Other Legacy$701,000 Foam FranchiseProducts Amzeeq Zilxi$1,311,000 Accutane$2,769,000 Qbrexza$7,361,000 Emrosi$4,883,000 Loss before incometaxes-$2,315,000 Total other revenues$606,000 Product revenue, net$17,025,000 Total other expense(income)-$786,000 Loss from operations-$1,529,000 Interest income$154,000 Total revenue$17,631,000 Foreign exchangetransaction losses-$3,000 Interest expense$937,000 Total operatingexpenses$19,160,000 Selling, general andadministrative$12,054,000 Research and development$287,000 Amortization of acquiredintangible assets$1,064,000 Cost of goods sold -(excluding amortization of...$5,755,000

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)